Company Filing History:
Years Active: 2006-2010
Title: The Innovations of Boris Fedotev
Introduction
Boris Fedotev is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of candesartan cilexetil forms and their preparation methods. With a total of 2 patents to his name, Fedotev's work has had a meaningful impact on the industry.
Latest Patents
His latest patents include innovative methods for the preparation of candesartan cilexetil polymorphs. These patents provide various forms of candesartan cilexetil and outline methods for their preparation. Additionally, he has developed processes for synthesizing cilexetil trityl candesartan, which involves the reaction of trityl candesartan with cilexetil halide in the presence of a base and a low boiling organic solvent. The option to conduct the reaction with a phase transfer catalyst further enhances the versatility of his inventions.
Career Highlights
Boris Fedotev is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative drug formulations and processes that contribute to the advancement of medical treatments.
Collaborations
Throughout his career, Fedotev has collaborated with talented professionals in the field, including Marina Etinger and Ben-Zion Dolitzky. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Boris Fedotev's contributions to the pharmaceutical industry through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in drug formulation and preparation methods.